We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

NOV 1 2024

Demand for Obesity Drugs Pressures FDA's Shortage Review - Bloomberg Law

William Garvin, shareholder and co-chair of the firm's FDA section, was quoted in "Demand for Obesity Drugs Pressures FDA's Shortage Review" from Bloomberg Law.